Drug Type Monoclonal antibody |
Synonyms STW292 |
Target |
Mechanism CD38 modulators(Lymphocyte differentiation antigen CD38 modulators) |
Therapeutic Areas |
Active Indication |
Inactive Indication- |
Originator Organization |
Active Organization |
Inactive Organization- |
Drug Highest PhasePreclinical |
First Approval Date- |
Regulation- |
Indication | Highest Phase | Country/Location | Organization | Date |
---|---|---|---|---|
Multiple Myeloma | Preclinical | CN | 30 Jan 2022 |